FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:912-914 September 20, 2001 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Emanuel, E. J. PubMed Citation

The use of placebo-controlled trials began just before World War II, and the Declaration of Helsinki, which arose from the Nuremberg Code, was formulated after the war. Placebo-controlled studies soon became the gold standard of evidence, and the Declaration of Helsinki became the gold standard of research ethics. However, the practices of the first collided with the principles of the second, and researchers and ethicists have been trying to resolve this problem ever since. The debate over placebo-controlled trials is implicitly and inextricably linked to concern about withholding treatment — specifically, withholding proven or standard treatment — in the course . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Strauss, M. H., Hall, A. S. (2006). Angiotensin Receptor Blockers May Increase Risk of Myocardial Infarction: Unraveling the ARB-MI Paradox. Circulation 114: 838-854 [Full Text]  
• Bola, J. R (2006). Medication-Free Research in Early Episode Schizophrenia: Evidence of Long-Term Harm?. Schizophr Bull 32: 288-296 [Abstract] [Full Text]  
• Woods, S. W., Gueorguieva, R. V., Baker, C. B., Makuch, R. W. (2005). Control Group Bias in Randomized Atypical Antipsychotic Medication Trials for Schizophrenia. Arch Gen Psychiatry 62: 961-970 [Abstract] [Full Text]  
• Kenkre, J. E., Semple, M. (2003). Research fraud: Why nurses should become aware. Journal of Research in Nursing 8: 47-56 [Abstract]  
• Hirsch, I. B., Coviello, A., Mazuski, J. E., Bailey, J. A., Shapiro, M. J., McCowen, K. C., Maykel, J. A., Bistrian, B. R., Nusbaum, N. J., van den Berghe, G., Bouillon, R., Lauwers, P. (2002). Intensive Insulin Therapy in Critically Ill Patients. NEJM 346: 1586-1588 [Full Text]  
• Nuechterlein, K. H., Huston, P., Peterson, R. (2002). Withholding Proven Treatment in Research. NEJM 346: 455-456 [Full Text]  
• Farquhar, D. (2001). Angiotensin-II-receptor blockers and nephropathy in patients with type 2 diabetes. CMAJ 165: 1379-1379 [Full Text]